Advertisement
Loading...

Kamada Ltd.

KMDA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.71
$-0.32(-3.93%)
U.S. Market opens in 28h 26m

Kamada Ltd. (KMDA) Stock Overview

Explore Kamada Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap444.8M
P/E Ratio21.94
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$7.45
3 Months$7.55
1 Year Target$9.13

KMDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kamada Ltd. (KMDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.94 and a market capitalization of 444.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.93%
5-Day Change
-9.61%
1-Month Change
-8.65%
3-Month Change
-9.29%
6-Month Change
10.30%
Year-to-Date (YTD) Change
9.21%
1-Year Change
12.39%
3-Year Change
61.97%
5-Year Change
32.47%
All-Time (Max) Change
-26.85%

Contact Information

https://www.kamada.com
972 8 940 6472
2 Holzman Street, Rehovot, NaN, 7670402

Company Facts

420 Employees
IPO DateMay 31, 2013
CountryIL
Actively Trading

Frequently Asked Questions